Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 2 publications
Marked and Durable Response to DLL3-Directed T-Cell Engager Tarlatamab in a Patient With Metastatic Pulmonary Large Cell Neuroendocrine Carcinoma: A Case Report.
Journal: Clinical lung cancer
Published: January 29, 2026
Showing 1-2 of 2
Last Updated: 09/26/2026